Breast Cancer Drug Newly Approved

Truqap to treat breast cancer

November 17, 2023 ,

Drug Name: Truqap

Active Ingredient: capivasertib

Indication: An AKT inhibitor used in combination with fulvestrant for the treatment of advanced HR-positive breast cancer

Approval Date: 11/16/2023

Company: AstraZeneca

More: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-capivasertib-fulvestrant-breast-cancer

Related

Drug Newly Approved

Defencath as a Catheter Lock Solution

November 16, 2023
Drug Newly Approved Non-Small Cell Lung Cancer

Augtyro to treat non-small cell lung cancer

November 15, 2023
Colorectal Cancer Drug Newly Approved

Fruzaqla to treat colorectal cancer

November 9, 2023

Leave a Reply

Your email address will not be published. Required fields are marked *